Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v10.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (50426)
CDC/NIH Web Information Database (32266)
CDC-Authored Genomics and Precision Health Publications Database (6442)
Precision Health Database (64289)
Pathogen Advanced Molecular Detection Database (28123)
All of Us Reports and Publications Database (1207)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (234259)
Epigenetic Epidemiology Publications Database (24135)
Release Note
Contact Us
CDC-Authored Genomics and Precision Health Publications Database|Home|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
CDC-Authored Genomics and Precision Health Publications Database
Last data update: Dec 09, 2024
. (Total: 6442 publications)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
Filtered By:
Select to fine-tune your search
Year
Journal
Records 1-6 (of 6 Records)
Query Trace:
Ciesla AA[original query]
Effectiveness of bivalent mrna vaccines in preventing symptomatic SARS-CoV-2 infection-increasing community access to testing program, United States, January-September 2023
Ciesla AA
,
Mak J
,
Roper LE
,
Fleming-Dutra KE
,
Smith ZR
,
Wiegand RE
,
Britton A
,
Miller J
,
Link-Gelles R
.
Influenza Other Respir Viruses 2024 18 (11) e70038
Early estimates of updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults - increasing community access to testing program, United States, September 2023-January 2024
Link-Gelles R
,
Ciesla AA
,
Mak J
,
Miller JD
,
Silk BJ
,
Lambrou AS
,
Paden CR
,
Shirk P
,
Britton A
,
Smith ZR
,
Fleming-Dutra KE
.
MMWR Morb Mortal Wkly Rep 2024 73 (4) 77-83
Previous infection and effectiveness of COVID-19 vaccination in middle- and high-school students
Almendares OM
,
Ruffin JD
,
Collingwood AH , Nolen LD ,
Lanier WA
,
Dash SR ,
Ciesla AA
,
Wiegand R
,
Tate JE
,
Kirking HL
.
Pediatrics 2023 152 (6)
Effectiveness of monovalent and bivalent mRNA vaccines in preventing COVID-19-associated emergency department and urgent care encounters among children aged 6 months-5 years - VISION Network, United States, July 2022-June 2023
Link-Gelles R
,
Ciesla AA
,
Rowley EAK , Klein NP , Naleway AL ,
Payne AB
,
Kharbanda A , Natarajan K , DeSilva MB , Dascomb K , Irving SA , Zerbo O , Reese SE ,
Wiegand RE
,
Najdowski M
,
Ong TC , Rao S , Stockwell MS , Stephens A , Goddard K , Martinez YC , Weber ZA , Fireman B , Hansen J , Timbol J , Grannis SJ , Barron MA , Embi PJ , Ball SW , Gaglani M , Grisel N , Arndorfer J ,
Tenforde MW
,
Fleming-Dutra KE
.
MMWR Morb Mortal Wkly Rep 2023 72 (33) 886-892
Effectiveness of booster doses of monovalent mRNA COVID-19 vaccine against symptomatic severe acute respiratory syndrome coronavirus 2 infection in children, adolescents, and adults during omicron subvariant BA.2/BA.2.12.1 and BA.4/BA.5 predominant periods
Ciesla AA
,
Wiegand RE
,
Smith ZR
,
Britton A
,
Fleming-Dutra KE
,
Miller J
,
Accorsi EK
,
Verani JR
,
Shang N
,
Derado G
,
Pilishvili T
,
Link-Gelles R
.
Open Forum Infect Dis 2023 10 (5) ofad187
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R
,
Ciesla AA
,
Roper LE
,
Scobie HM
,
Ali AR
,
Miller JD
,
Wiegand RE
,
Accorsi EK
,
Verani JR
,
Shang N
,
Derado G
,
Britton A
,
Smith ZR
,
Fleming-Dutra KE
.
MMWR Morb Mortal Wkly Rep 2023 72 (5) 119-124
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP